Venus Remedies Limited (BOM:526953)
1,221.80
+58.15 (5.00%)
At close: May 27, 2026
Venus Remedies Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 296.1 | 722.11 | 647.19 | 212.12 | 432.56 |
Short-Term Investments | 738 | 840.85 | 190.86 | 508.65 | - |
Cash & Short-Term Investments | 1,034 | 1,563 | 838.05 | 720.77 | 432.56 |
Cash Growth | -33.84% | 86.50% | 16.27% | 66.63% | 49.78% |
Accounts Receivable | 1,033 | 1,122 | 804.98 | 766.6 | 386 |
Other Receivables | 81.8 | 120.95 | 299.35 | 301.75 | 326.94 |
Receivables | 1,115 | 1,248 | 1,110 | 1,069 | 716.14 |
Inventory | 1,294 | 1,005 | 1,217 | 1,199 | 1,256 |
Prepaid Expenses | - | 4.99 | 6.34 | 6.74 | 4.98 |
Other Current Assets | 509.6 | 696.37 | 424.36 | 232.63 | 370.28 |
Total Current Assets | 3,952 | 4,517 | 3,595 | 3,228 | 2,780 |
Property, Plant & Equipment | 1,890 | 1,511 | 1,544 | 1,628 | 1,782 |
Long-Term Investments | 1,638 | 0.18 | 0.18 | - | - |
Other Intangible Assets | 939.8 | 1,047 | 852.11 | 792.46 | 879.29 |
Long-Term Deferred Tax Assets | - | - | - | - | 6.82 |
Other Long-Term Assets | 117.2 | 81.77 | 276.64 | 361.85 | 349.27 |
Total Assets | 8,537 | 7,157 | 6,268 | 6,011 | 5,798 |
Accounts Payable | 1,135 | 918.6 | 531.83 | 508.4 | 501.67 |
Accrued Expenses | - | 144.02 | 92.58 | 134.67 | 167.7 |
Short-Term Debt | - | 16.93 | 26.46 | 36.14 | 40.64 |
Current Portion of Long-Term Debt | - | - | - | - | 1.02 |
Current Portion of Leases | 13.6 | - | - | - | - |
Other Current Liabilities | 469.1 | 283.35 | 143.29 | 146.49 | 216.36 |
Total Current Liabilities | 1,618 | 1,363 | 794.16 | 825.7 | 927.39 |
Long-Term Debt | - | - | 386.79 | 386.79 | 386.79 |
Long-Term Leases | 110.5 | - | - | - | - |
Pension & Post-Retirement Benefits | - | - | 77.6 | 65.77 | 52.05 |
Long-Term Deferred Tax Liabilities | 143.4 | 155.85 | 109.19 | 106.49 | - |
Other Long-Term Liabilities | 28 | 28.99 | 24.98 | 22.69 | 27.49 |
Total Liabilities | 1,900 | 1,548 | 1,393 | 1,407 | 1,394 |
Common Stock | 133.7 | 133.67 | 133.67 | 133.67 | 133.67 |
Additional Paid-In Capital | - | 883.28 | 883.28 | 883.28 | 883.28 |
Retained Earnings | - | 4,555 | 3,819 | 3,536 | 3,275 |
Comprehensive Income & Other | 6,504 | 37.6 | 39.61 | 50.5 | 112.64 |
Shareholders' Equity | 6,638 | 5,609 | 4,876 | 4,603 | 4,404 |
Total Liabilities & Equity | 8,537 | 7,157 | 6,268 | 6,011 | 5,798 |
Total Debt | 124.1 | 16.93 | 413.25 | 422.93 | 428.45 |
Net Cash (Debt) | 910 | 1,546 | 424.8 | 297.84 | 4.11 |
Net Cash Growth | -41.14% | 263.95% | 42.63% | 7153.70% | - |
Net Cash Per Share | 68.08 | 115.66 | 31.78 | 22.28 | 0.31 |
Filing Date Shares Outstanding | 13.37 | 13.37 | 13.37 | 13.37 | 13.37 |
Total Common Shares Outstanding | 13.37 | 13.37 | 13.37 | 13.37 | 13.37 |
Working Capital | 2,334 | 3,154 | 2,801 | 2,403 | 1,853 |
Book Value Per Share | 496.59 | 419.65 | 364.74 | 344.38 | 329.50 |
Tangible Book Value | 5,698 | 4,562 | 4,023 | 3,811 | 3,525 |
Tangible Book Value Per Share | 426.28 | 341.31 | 300.99 | 285.10 | 263.72 |
Land | - | 118.13 | 114.04 | 114.04 | - |
Buildings | - | 1,016 | 991.5 | 925 | - |
Machinery | - | 2,307 | 2,424 | 2,510 | - |
Construction In Progress | - | 263.9 | 210.84 | 260.98 | 252.33 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.